Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells

Colorectal cancer (CRC) is a common and life-threatening type of malignant cancer, which is associated with a high mortality rate. Cisplatin (CDDP) is a commonly used chemotherapy drug with significant side effects. Brusatol (BR) is one of the principal chemical compounds isolated from the Chinese h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Med
Autores principales: Chen, Hai-Ming, Lai, Zheng-Quan, Liao, Hui-Jun, Xie, Jian-Hui, Xian, Yan-Fang, Chen, Yun-Long, Ip, Siu-Po, Lin, Zhi-Xiu, Su, Zi-Ren
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819912/
https://ncbi.nlm.nih.gov/pubmed/29328398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3372
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares